Funding Update

UFHCC + Extramural Opportunities

UFHCC Opportunities

This is a selected list of internal cancer-focused funding opportunities. To stay updated, visit our webpage.

UFHCC Bridge Grants

This Bridge Grant Program is designed to support promising new research or competitive renewals that have nearly missed funding pay lines. The research must have strong cancer relevance; clinical, basic and population research grants are all acceptable. The maximum award for these grants is $75,000 direct cost for R01s and $50,000 for R21s. No IDC is allowed.

Applications will be accepted on a rolling basis. Applicants should submit their full federal proposal with a screenshot of their score/percentile to ResearchAdmin@cancer.ufl.edu.

For more information, see the UFHCC Bridge Grants page.

Other UF Opportunities

Clinical and Translational Science Institute

Patient Oriented Clinical Research
Application due date: Rolling basis through March 31, 2018

Extramural Opportunities

Other Extramural Opportunities (Selected)

National Institutes of Health

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 – Clinical Trial Optional)
Application due date: 3/16/18

Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional)
Application due date: 3/16/18

Administrative Supplement for Research on Sex/Gender Influences
Application due date: 3/26/18

Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31 – Diversity)
Application due date: 4/8/18

Research Grants
Application due date: 5/25/18

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Application due date: 6/5/18

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Application due date: 6/19/18

Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Application due date: 6/19/18

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
LOI due date: 7/15/18 Application due date: 8/15/18

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
Due dates vary by awarding IC

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required)
Application due date: 3/6/18

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) (R21 Clinical Trial Optional)
LOI due date: 3/11/18 Application due date: 4/11/18

Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional)
LOI due date: 3/11/18 Application due date: 4/11/18

Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)
LOI due date: 4/9/18 Application due date: 5/9/18

Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional)
LOI due date: 4/9/18 Application due date: 5/9/18

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) (R21 Clinical Trial Optional)
Application due date: 4/11/18

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) (R21 Clinical Trial Optional)
LOI due date: 4/30/18 Application due date: 5/30/18

Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional)
LOI due date: 5/5/18 Application due date: 6/5/18

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Application due date: 6/5/18

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 Clinical Trial Optional) (R21 Clinical Trial Optional)
Application due date: 6/13/18

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional) (R21 Clinical Trial Optional)
Application due date: 6/27/18

Circle of Hope for Cancer Research

Two awards of $10,000 are available for young investigators pursuing careers in cancer research.

Request application information and submit LOI to: bvalentine@health.ufl.edu
LOI due date: 2/28/18

The Sontag Foundation

2018 Distinguished Scientist Award
Application due date: 3/14/18

Pfizer

Advances in Adjuvant Treatment in Renal Cell Carcinoma (RCC)
Application due date: 3/15/18

EGFR Targeted-Therapies in Lung Cancer
Application due date: 3/15/18

Treatment Advances in Chronic Myelogenous Leukemia (CML)
Application due date: 3/15/18

Prostate Cancer Foundation

2018 Young Investigator Awards
Application due date: 3/19/18

2018 PCF Challenge Awards
Application due date: 4/23/18